Journal Article10.1056/NEJMOA1414792
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
Bruce C.V. Campbell,Leonid Churilov,Nawaf Yassi,Bernard Yan,M. Brooks,F. Miteff,Martin Krause,M. Priglinger,Timothy Ang,Rebecca Scroop,Ben McGuinness,Tissa Wijeratne,Winston Chong,Monica S Badve,H. Rice,L. de Villiers,Henry Ma,Abstr Act +17 more
TL;DR: In patients with ischemic stroke with a proximal cerebral arterial occlusion and salvageable tissue on CT perfusion imaging, early thrombectomy with the Solitaire FR stent retriever, as compared with alteplase alone, improved reperfusion, early neurologic recovery, and functional outcome.
read more
Abstract: Background Trials of endovascular therapy for ischemic stroke have produced variable results. We conducted this study to test whether more advanced imaging selection, recently developed devices, and earlier intervention improve outcomes. Methods We randomly assigned patients with ischemic stroke who were receiving 0.9 mg of alteplase per kilogram of body weight less than 4.5 hours after the onset of ischemic stroke either to undergo endovascular thrombectomy with the Solitaire FR (Flow Restoration) stent retriever or to continue receiving alteplase alone. All the patients had occlusion of the internal carotid or middle cerebral artery and evidence of salvageable brain tissue and ischemic core of less than 70 ml on computed tomographic (CT) perfusion imaging. The coprimary outcomes were reperfusion at 24 hours and early neurologic improvement (≥8-point reduction on the National Institutes of Health Stroke Scale or a score of 0 or 1 at day 3). Secondary outcomes included the functional score on the modified Rankin scale at 90 days. Results The trial was stopped early because of efficacy after 70 patients had undergone randomization (35 patients in each group). The percentage of ischemic territory that had undergone reperfusion at 24 hours was greater in the endovascular-therapy group than in the alteplase-only group (median, 100% vs. 37%; P<0.001). Endovascular therapy, initiated at a median of 210 minutes after the onset of stroke, increased early neurologic improvement at 3 days (80% vs. 37%, P = 0.002) and improved the functional outcome at 90 days, with more patients achieving functional independence (score of 0 to 2 on the modified Rankin scale, 71% vs. 40%; P = 0.01). There were no significant differences in rates of death or symptomatic intracerebral hemorrhage. Conclusions In patients with ischemic stroke with a proximal cerebral arterial occlusion and salvageable tissue on CT perfusion imaging, early thrombectomy with the Solitaire FR stent retriever, as compared with alteplase alone, improved reperfusion, early neurologic recovery, and functional outcome. (Funded by the Australian National Health and Medical Research Council and others; EXTEND-IA ClinicalTrials.gov number, NCT01492725, and Australian New Zealand Clinical Trials Registry number, ACTRN12611000969965.)
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Trim47 is a critical regulator of cerebral ischemia-reperfusion injury through regulating apoptosis and inflammation.
TL;DR: A new mechanism for the effect of Trim 47 on cerebral I/R injury is demonstrated, and targeting Trim47 might provide feasible therapies for stroke treatment.
42
Mechanical Thrombectomy for Acute Ischemic Stroke Secondary to Infective Endocarditis.
Juan Ambrosioni,Xabier Urra,Marta Hernández-Meneses,Manel Almela,Carlos Falces,Adrián Téllez,Eduard Quintana,David Fuster,Elena Sandoval,Barbara Vidal,José María Tolosana,Asunción Moreno,Ángel Chamorro,José M. Miró +13 more
TL;DR: The initial experience in 6 cases of proximal vessel occlusion treated with mechanical thrombectomy was safe (no bleeding) and effective and might be useful in this clinical setting.
Intravenous Thrombolysis and Passes of Thrombectomy as Predictors for Endovascular Revascularization in Ischemic Stroke.
A. Angermaier,Patrik Michel,Alexander V. Khaw,Michael Kirsch,Christof Kessler,Soenke Langner +5 more
TL;DR: In this paper, the authors performed univariate and multivariate regression analyses to identify predictors of revascularization (thrombolysis in cerebral infarction ≥2b) after ERT.
42
Paths to Successful Translation of New Therapies for Severe Traumatic Brain Injury in the Golden Age of Traumatic Brain Injury Research: A Pittsburgh Vision.
Patrick M. Kochanek,Patrick M. Kochanek,Travis C. Jackson,Travis C. Jackson,Ruchira M. Jha,Ruchira M. Jha,Robert S. B. Clark,Robert S. B. Clark,David O. Okonkwo,Hülya Bayır,Hülya Bayır,Samuel M. Poloyac,Samuel M. Poloyac,Amy K. Wagner,Amy K. Wagner,Philip E. Empey,Philip E. Empey,Yvette P. Conley,Michael J. Bell,Anthony E. Kline,Anthony E. Kline,Corina O. Bondi,Corina O. Bondi,Dennis W. Simon,Dennis W. Simon,Shaun W. Carlson,Shaun W. Carlson,Ava M. Puccio,Christopher M. Horvat,Christopher M. Horvat,Alicia K. Au,Alicia K. Au,Jonathan Elmer,Amery Treble-Barna,Amery Treble-Barna,Milos D. Ikonomovic,Lori Shutter,D. Lansing Taylor,Andrew M. Stern,Steven H. Graham,Valerian E. Kagan,Edwin K. Jackson,Stephen R. Wisniewski,C. Edward Dixon +43 more
TL;DR: An approach to deliver therapeutic breakthroughs in this golden age of TBI research is synthesized, presenting concepts for traditional and novel approaches to defining therapeutic targets.
Emerging therapies in acute ischemic stroke
Nicholas Liaw,David S Liebeskind +1 more
TL;DR: Stroke-systems-of-care models continue to streamline the delivery of definitive revascularization in the age of mechanical thrombectomy and technologies such as telestroke, mobile stroke units, and artificial intelligence are playing an increasing role in identifying and treating stroke.
References
A Simple Sequentially Rejective Multiple Test Procedure
TL;DR: In this paper, a simple and widely accepted multiple test procedure of the sequentially rejective type is presented, i.e. hypotheses are rejected one at a time until no further rejections can be done.
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
Debbie Beumer,Debbie Beumer,Julie Staals,Jeannette Hofmeijer,Jelis Boiten,J. De Vries,Omid S. Eshghi,Koos Keizer,R. van den Berg,A. van der Lugt,Abstr Act +10 more
TL;DR: In patients with acute ischemic stroke caused by a proximal intracranial occlusion of the anterior circulation, intraarterial treatment administered within 6 hours after stroke onset was effective and safe.
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
Nils Wahlgren,Niaz Ahmed,Antoni Dávalos,Gary A. Ford,Martin Grond,Werner Hacke,Michael G. Hennerici,Markku Kaste,Sonja Kuelkens,Vincent Larrue,Kennedy R. Lees,Risto O. Roine,Lauri Soinne,Danilo Toni,Geert Vanhooren +14 more
TL;DR: These data confirm that intravenous alteplase is safe and effective in routine clinical use when used within 3 h of stroke onset, even by centres with little previous experience of thrombolytic therapy for acute stroke.
2K
•Journal Article
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study (vol 369, pg 275, 2007)
TL;DR: The Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) as discussed by the authors was required to assess the safety profile of intravenous alteplase in clinical practice by comparison with results in randomised controlled trials.
1.9K
Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke
Joseph P. Broderick,Yuko Y. Palesch,Andrew M. Demchuk,Sharon D. Yeatts,Pooja Khatri,Michael D. Hill,Edward C. Jauch,Tudor G Jovin,Bernard Yan,Frank L. Silver,Ruediger von Kummer,Carlos A. Molina,Bart M. Demaerschalk,Ronald F. Budzik,Wayne M. Clark,Osama O. Zaidat,Tim W. Malisch,Mayank Goyal,Wouter J. Schonewille,Mikael Mazighi,Stefan T. Engelter,Craig S. Anderson,Judith Spilker,Janice Carrozzella,Karla J Ryckborst,L. Scott Janis,Renee H Martin,Lydia D. Foster,Thomas A. Tomsick +28 more
TL;DR: The trial showed similar safety outcomes and no significant difference in functional independence with endovascular therapy after intravenous t-PA, as compared with intravenoust-PA alone.
Related Papers (5)
Jeffrey L. Saver,Mayank Goyal,Alain Bonafe,Hans-Christoph Diener,Elad I. Levy,Vitor Mendes Pereira,Gregory W. Albers,Christophe Cognard,David J. Cohen,Werner Hacke,Olav Jansen,Tudor G Jovin,Heinrich Mattle,Raul G Nogueira,Adnan H. Siddiqui,Dileep R. Yavagal,Blaise Baxter,Thomas Devlin,Demetrius K. Lopes,Vivek Y. Reddy,Richard du Mesnil de Rochemont,Oliver C. Singer,Reza Jahan +22 more
A. Chamorro,Erik Cobo,Alex Rovira,L. San Román,Joaquín Serena,Sònia Abilleira,Marc Ribo,Mónica Millán,Xabier Urra,Pedro Cardona,E. López-Cancio,Alejandro Tomasello,Carlos Castaño,Jordi Blasco,Lucia Aja,Laura Dorado,Helena Quesada,Marta Rubiera,María Hernández-Pérez,Mayank Goyal,R. von Kummer,Antonio Dávalos +21 more
Mayank Goyal,Bijoy K Menon,Wim H. van Zwam,Diederik W.J. Dippel,Peter Mitchell,Andrew M. Demchuk,Antoni Dávalos,Charles B. L. M. Majoie,Aad van der Lugt,Maria Angeles De Miquel,Geoffrey A. Donnan,Yvo B.W.E.M. Roos,Alain Bonafe,Reza Jahan,Hans-Christoph Diener,Lucie A. van den Berg,Elad I. Levy,Olvert A. Berkhemer,Vitor Mendes Pereira,Jeremy L. Rempel,Mónica Millán,Stephen M. Davis,Daniel Roy,John Thornton,Luis San Roman,Marc Ribo,Debbie Beumer,Bruce Stouch,Scott Brown,Bruce C.V. Campbell,Robert J. van Oostenbrugge,Jeffrey L. Saver,Michael D. Hill,Tudor G Jovin +33 more